Skip to main content

Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio

The biopharmaceutical company Jazz Pharmaceuticals, has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.